December 1, 2022
Ultragenyx Pharmaceutical aims to lay the groundwork for growth in the Japan market with its recently launched Mepsevii (vestronidase alfa) and forge ahead with the rollout of another ultra-orphan drug evinacumab in 2024. The company hopes to bring all nine...read more